The Federal Circuit’s March 19, 2008, decision in Amgen Inc. v. International Trade Commission, No: 2007-1014 (Fed. Cir. 2008), significantly expanded both the ITC’s jurisdiction to conduct investigations and the defenses available to some accused infringers.
This decision, by a split panel, will have important effects on the frequency and scope of Section 337 investigations of alleged patent infringement involving FDA-regulated products.
Read the complete article by clicking on the link below.
Reprinted with permission from Portfolio Media, Inc.
Related Insights
24 October 2024
Events
The Future of AI in the Consumer Goods Industry
Join us on October 24 for a panel made up of Artificial Intelligence (AI) experts from academia and industry.
07 October 2024
Labor & Employment Law Perspectives
Illinois Updates Its Law Governing Use of Staffing Agencies — Again
The Illinois General Assembly has been busy at work revising and updating the Illinois Day and Temporary Labor Services Act.
07 October 2024
Labor & Employment Law Perspectives
Disappearing Messages, Unofficial Communications Platforms and Ever-Increasing Scrutiny by Regulators
Corporate use of third-party messaging platforms, including ephemeral messaging tools (which allow messages to disappear), is quite common and has become both a cost efficiency for employers and a convenient way for employees to communicate quickly with colleagues and clients.